GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moogene Medi Co Ltd (XKRX:322970) » Definitions » Net Income From Continuing Operations

Moogene Medi Co (XKRX:322970) Net Income From Continuing Operations : ₩0.00 Mil (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is Moogene Medi Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Moogene Medi Co's net income from continuing operations for the six months ended in . 20 was ₩0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.

Moogene Medi Co Net Income From Continuing Operations Historical Data

The historical data trend for Moogene Medi Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moogene Medi Co Net Income From Continuing Operations Chart

Moogene Medi Co Annual Data
Trend
Net Income From Continuing Operations

Moogene Medi Co Semi-Annual Data
Net Income From Continuing Operations

Moogene Medi Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 was ₩0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Moogene Medi Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moogene Medi Co Ltd (XKRX:322970) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:179530 XKRX:298060 XKRX:065650 XKRX:188260 XKRX:446440 XKRX:327610 XKRX:251280 XKRX:343090 XKRX:341170 XKRX:344860 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
670, Daewangpangyo-ro, Bundang-gu, U-space 2 A-505, Gyeonggi-do, Seongnam-si, KOR
Website
http://www.moogene.com
Moogene Medi Co Ltd is a bio-technology company engaged in gene therapy and nano-materials fabrication using cutting-edge nanotechnologies. The company has developed programs to monitor KRAS-mutant cancer strains, androgenic alopecia, type two diabetes, and liver diseases.

Moogene Medi Co Headlines

No Headlines